Bank Of New York Mellon Corp Y M Abs Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.0 - $15.17 $340,020 - $1.72 Million	113,340 New	113,340 $553,000
Q3 2022 Nov 14, 2022	BUY	$13.96 - $19.67 $149,344 - $210,429	10,698 Added 10.42%	113,355 $1.63 Million
Q2 2022 Aug 15, 2022	SELL	$8.22 - $15.13 $12,149 - $22,362	-1,478 Reduced 1.42%	102,657 $1.55 Million
Q1 2022 May 11, 2022	BUY	$6.55 - $17.42 $5,174 - $13,761	790 Added 0.76%	104,135 $1.24 Million
Q4 2021 Feb 11, 2022	SELL	$15.51 - $29.31 $4,482 - $8,470	-289 Reduced 0.28%	103,345 $1.68 Million
Q3 2021 Nov 12, 2021	BUY	$27.47 - $37.31 $329,859 - $448,018	12,008 Added 13.11%	103,634 $2.96 Million
Q2 2021 Aug 11, 2021	SELL	$25.45 - $37.64 $236,277 - $349,449	-9,284 Reduced 9.2%	91,626 $3.1 Million
Q1 2021 May 13, 2021	SELL	$29.16 - $51.96 $199,716 - $355,874	-6,849 Reduced 6.36%	100,910 $3.05 Million
Q4 2020 Feb 09, 2021	BUY	$37.86 - $54.26 $100,329 - $143,789	2,650 Added 2.52%	107,759 $5.34 Million
Q3 2020 Nov 12, 2020	BUY	$35.13 - $43.62 $17,775 - $22,071	506 Added 0.48%	105,109 $4.04 Million
Q2 2020 Aug 12, 2020	BUY	$23.66 - $49.53 $452,852 - $948,004	19,140 Added 22.4%	104,603 $4.52 Million
Q1 2020 May 06, 2020	BUY	$14.39 - $35.8 $23,470 - $58,389	1,631 Added 1.95%	85,463 $2.23 Million
Q4 2019 Feb 14, 2020	BUY	$23.81 - $33.78 $591,226 - $838,791	24,831 Added 42.09%	83,832 $2.62 Million
Q3 2019 Nov 07, 2019	BUY	$21.57 - $31.37 $25,280 - $36,765	1,172 Added 2.03%	59,001 $1.54 Million
Q2 2019 Aug 12, 2019	BUY	$19.51 - $28.31 $733,751 - $1.06 Million	37,609 Added 186.0%	57,829 $1.32 Million
Q1 2019 May 14, 2019	BUY	$18.21 - $26.21 $368,206 - $529,966	20,220 New	20,220 $530,000

Others Institutions Holding YMAB

# of Institutions

106

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

Paradigm Biocapital Advisors LP New York, NY

4.09M
Shares

$33.3 Million
1.93% of portfolio
Black Rock Inc. New York, NY

2.94M
Shares

$24 Million
0.0% of portfolio
Sofinnova Investments, Inc. Menlo Park, CA

2.19M
Shares

$17.9 Million
2.73% of portfolio
Vanguard Group Inc Valley Forge, PA

2.04M
Shares

$16.6 Million
0.0% of portfolio
Polar Capital Holdings PLC London, X0

1.83M
Shares

$14.9 Million
0.15% of portfolio

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account